Sandbox Reserved 1237: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older editNewer edit →
Adam Rork (talk | contribs)
22 edits
No edit summary
Adam Rork (talk | contribs)
22 edits
No edit summary
Line 40: Line 40:


== References ==
== References ==
1. Fraser, M.E, M. Fujinaga, M.M Cherney, A.R Melton-Celsa, E.M Twiddy, A.D O'Brien, and M.N.G. James. "Structure of Shiga Toxin Type 2 (Stx2) from Escherichia Coli O157:H7." J.Biol.Chem. Journal of Biological Chemistry, n.d. Web. 04 May 2017.  
1. Fraser ME, et al. "Structure of Shiga Toxin Type 2 (Stx2) from Escherichia Coli O157:H7." J.Biol.Chem. 279(26). (2004). 27511-7


2. http://www.rcsb.org/pdb/explore/explore.do?structureId=1R4P
2. http://www.rcsb.org/pdb/explore/explore.do?structureId=1R4P
3. Römer W, et al. "Shiga toxin induces tubular membrane invaginations for its uptake into cells." Nature. (2007). 450(7170):670-675
4. Ray PE, Lui XH. "Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome." Pediatr Nephrol. 2001. 16(10):823-39
5.O'Loughlin EV, Robins-Brown RM. "Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells." Microbes Infect. (2001). 3(6):492-507
6. Melton-Celsa AR. “Shiga Toxin (Stx) Classification, Structure, and Function.” Microbiology spectrum. (2014). 2(2):PMC
7. Mayer CL, Leibowitz CS, Kurosawa S, Stearns-Kurosawa DJ. "Shiga Toxins and the Pathophysiology of Hemolytic Uremic Syndrome in Humans and Animals." Toxins. (2012). 4(11):1261-1287
<references/>
<references/>
Retrieved from "https://proteopedia.org/Sandbox_Reserved_1237"